Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
2 Views
administrator
08/04/23
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
-
Category
Show more
Facebook Comments
No comments found